Entertainment news and discussion on TalkFuse.
Why Hollywood’s Follicle-Challenged Stars Are Harvesting Their Hair
The article says a new frontier in hair restoration is attracting strong interest in Hollywood: “hair banking”, in which healthy follicles are removed and frozen now in the hope they can support more advanced regenerative treatments later, including possible follicle cloning. It matters because current options such as minoxidil, finasteride and transplants have limits, especially the restricted supply of donor hair, while doctors and researchers see cell-based approaches as a potential way to restore hair more effectively in future.
The piece explains that a typical banking procedure removes about 50 healthy follicles in a 30-minute process without anaesthetic, after which they are tested and cryogenically stored. It also highlights experimental treatments made from a patient’s banked material, including “secretomes” and exosomes, which aim to repair follicles rather than merely slow hair loss; a 12-session secretome package is quoted at $12,000, with storage for up to two years, while standalone exosome sessions are said to cost roughly $1,500 to $5,000 and multi-session packages $3,000 to $10,000 or more. The article adds that the FDA could potentially approve a new hair-loss pill, VDPHL01, in early 2028, but suggests regenerative medicine may develop further over the next decade.
In short
- Hollywood is eyeing hair banking as a future-facing restoration strategy
- The goal is follicle repair and possible cloning, not just slowing loss
- Experimental treatments are costly and not yet a complete solution
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Advocates argue that hair banking represents legitimate advancement in regenerative medicine, offering informed patients meaningful autonomy to explore cutting-edge treatments that could transform restoration by overcoming the donor-hair limitations of traditional transplants. They contend that early adoption of novel techniques historically accelerates scientific progress, and that follicle cloning and cell-based therapies show genuine promise despite current regulatory status, making access to experimental options a matter of patient choice and self-determination.
The case against
Critics contend that these procedures exploit cosmetic insecurity by charging substantial sums for speculative treatments lacking rigorous FDA approval or long-term safety data. They argue that banking follicles for hypothetical future therapies amounts to indefinite biological storage at patient expense and risk, whilst pricing for unproven treatments reaching $3,000 to $12,000 per course targets vulnerable people when evidence-based alternatives remain far cheaper and better understood.
Explained simply
Hair loss has long been treated with medications like minoxidil and finasteride, which can slow hair loss, or transplants that move hair from one part of the scalp to another. Both approaches have significant limitations: medications work only temporarily and incompletely, whilst transplants are restricted by the limited amount of donor hair available from each patient.
Hair banking is a new procedure in which healthy hair follicles are removed and frozen for potential use in future regenerative treatments. The procedure is quick and non-invasive, typically extracting around 50 follicles in about 30 minutes without anaesthetic, after which they are tested and stored using cryogenic freezing.
Researchers believe that banked follicles could eventually be used to develop treatments that repair damaged hair follicles rather than merely slowing hair loss, potentially through advanced cell-based therapies. The approach has attracted significant interest from high-profile figures in Hollywood and elsewhere who are seeking more effective solutions to hair loss.